Difference between revisions of "Timeline of Schistosomiasis Control Initiative"
From Timelines
Line 21: | Line 21: | ||
| 2003 || || || SCI begins program in {{w|Zambia}}, {{w|Zanzibar}}, and {{w|Niger}}.<ref name="OUR REACH"/> || {{w|Zambia}}, {{w|Zanzibar}}, {{w|Niger}} | | 2003 || || || SCI begins program in {{w|Zambia}}, {{w|Zanzibar}}, and {{w|Niger}}.<ref name="OUR REACH"/> || {{w|Zambia}}, {{w|Zanzibar}}, {{w|Niger}} | ||
|- | |- | ||
− | | 2006 || || || | + | | 2006 || || Funding || SCI receives large grants from the {{w|United States Agency for International Development}} and the {{w|Bill & Melinda Gates Foundation}} to support integrated NTD programs in eight countries for five years to treat {{w|lymphatic filariasis}}, {{w|onchocerciasis}}, and {{w|trachoma}}, in addition to {{w|schistosomiasis}} and {{w|soil-transmitted helminths}}.<ref name="Schistosomiasis Control Initiative: Supplementary Information"/> || |
|- | |- | ||
− | | 2007 || || || SCI receives a grant to expand its work to {{w|Rwanda}} and {{w|Burundi}}.<ref name="Schistosomiasis Control Initiative: Supplementary Information"/> || | + | | 2007 || || Funding || SCI receives a grant to expand its work to {{w|Rwanda}} and {{w|Burundi}}.<ref name="Schistosomiasis Control Initiative: Supplementary Information"/> || |
|- | |- | ||
| 2007 || || || SCI program starts in Burundi.<ref name="OUR REACH">{{cite web |title=OUR REACH |url=https://www.schistosomiasiscontrolinitiative.org/our-reach |website=schistosomiasiscontrolinitiative.org |accessdate=12 March 2019}}</ref> || {{w|Burundi}} | | 2007 || || || SCI program starts in Burundi.<ref name="OUR REACH">{{cite web |title=OUR REACH |url=https://www.schistosomiasiscontrolinitiative.org/our-reach |website=schistosomiasiscontrolinitiative.org |accessdate=12 March 2019}}</ref> || {{w|Burundi}} | ||
Line 31: | Line 31: | ||
| 2010 || || || SCI receives £10.5 million (plus separate funding for drugs) from the British {{w|Department for International Development}} for treating schistosomiasis and {{w|soil-transmitted helminthiasis}} in eight countries over five years.<ref name="Schistosomiasis Control Initiative: Supplementary Information"/> || | | 2010 || || || SCI receives £10.5 million (plus separate funding for drugs) from the British {{w|Department for International Development}} for treating schistosomiasis and {{w|soil-transmitted helminthiasis}} in eight countries over five years.<ref name="Schistosomiasis Control Initiative: Supplementary Information"/> || | ||
|- | |- | ||
− | | 2010 || October || || | + | | 2010 || October || Funding || SCI receives £10.5 million (plus separate funding for drugs) from the British {{w|Department for International Development}} for treating schistosomiasis and {{w|soil-transmitted helminthiasis}} in eight countries over five years.<ref>{{cite web |title=Imperial initiative to protect children from tropical disease awarded £25m government backing |url=http://www.imperial.ac.uk/news/93621/imperial-initiative-protect-children-from-tropical/ |website=imperial.ac.uk |accessdate=11 March 2019}}</ref><ref name="Schistosomiasis Control Initiative: Supplementary Information"/> || |
|- | |- | ||
− | | 2011 || || || SCI begins program in Liberia, Malawi, and Mozambique.<ref name="OUR REACH"/> || {{w|Liberia}}, {{w|Malawi}}, {{w|Mozanbique}} | + | | 2011 || || Expansion || SCI begins program in Liberia, Malawi, and Mozambique.<ref name="OUR REACH"/> || {{w|Liberia}}, {{w|Malawi}}, {{w|Mozanbique}} |
|- | |- | ||
− | | 2012 || || || SCI program starts in Côte d'Ivoire, two years later due to political turmoil.<ref name="Schistosomiasis Control Initiative: Supplementary Information"/><ref name="OUR REACH"/> || {{w|Côte d'Ivoire}} | + | | 2012 || || Expansion || SCI program starts in Côte d'Ivoire, two years later due to political turmoil.<ref name="Schistosomiasis Control Initiative: Supplementary Information"/><ref name="OUR REACH"/> || {{w|Côte d'Ivoire}} |
|- | |- | ||
− | | 2012 || || || SCI begins conversations with the {{w|Government of Ethiopia}} about starting a national schistosomiasis treatment program.<ref name="Schistosomiasis Control Initiative: Supplementary Information"/> || {{w|Ethiopia}} | + | | 2012 || || Expansion || SCI begins conversations with the {{w|Government of Ethiopia}} about starting a national schistosomiasis treatment program.<ref name="Schistosomiasis Control Initiative: Supplementary Information"/> || {{w|Ethiopia}} |
|- | |- | ||
− | | 2012 || || || SCI reaches median coverage for schistosomiasis treatment at 77% in Malawi.<ref name="SCHISTOSOMIASIS CONTROL INITIATIVEd">{{cite web |title=SCHISTOSOMIASIS CONTROL INITIATIVE |url=https://www.givingwhatwecan.org/report/schistosomiasis-control-initiative/ |website=givingwhatwecan.org |accessdate=12 March 2019}}</ref> || | + | | 2012 || || Coverage || SCI reaches median coverage for schistosomiasis treatment at 77% in Malawi.<ref name="SCHISTOSOMIASIS CONTROL INITIATIVEd">{{cite web |title=SCHISTOSOMIASIS CONTROL INITIATIVE |url=https://www.givingwhatwecan.org/report/schistosomiasis-control-initiative/ |website=givingwhatwecan.org |accessdate=12 March 2019}}</ref> || |
|- | |- | ||
− | | 2013 || || || SCI begins first round of treatment in {{w|Ethiopia}} and {{w|Mauritania}}.<ref name="Schistosomiasis Control Initiative: Supplementary Information"/><ref name="OUR REACH"/><ref name="Schistosomiasis Control Initiative: Supplementary Information"/><ref name="OUR REACH"/> || {{w|Ethiopia}}, {{w|Mauritania}} | + | | 2013 || || Expansion || SCI begins first round of treatment in {{w|Ethiopia}} and {{w|Mauritania}}.<ref name="Schistosomiasis Control Initiative: Supplementary Information"/><ref name="OUR REACH"/><ref name="Schistosomiasis Control Initiative: Supplementary Information"/><ref name="OUR REACH"/> || {{w|Ethiopia}}, {{w|Mauritania}} |
|- | |- | ||
| 2013 – 2014 || Between November 2013 and April 2014 || || SCI funds mapping in {{w|Ethiopia}}.<ref name="Schistosomiasis Control Initiative: Supplementary Information"/> || {{w|Ethiopia}} | | 2013 – 2014 || Between November 2013 and April 2014 || || SCI funds mapping in {{w|Ethiopia}}.<ref name="Schistosomiasis Control Initiative: Supplementary Information"/> || {{w|Ethiopia}} | ||
|- | |- | ||
− | | 2014 || || || SCI begins program in the Democratic Republic of the Congo and Madagascar.<ref name="OUR REACH"/> || {{w|Democratic Republic of the Congo}}, {{w|Madagascar}} | + | | 2014 || || Expansion || SCI begins program in the Democratic Republic of the Congo and Madagascar.<ref name="OUR REACH"/> || {{w|Democratic Republic of the Congo}}, {{w|Madagascar}} |
|- | |- | ||
− | | 2014 || || || | + | | 2014 || || || SCI begins working with other partners in Côte d'Ivoire, including {{w|Sightsavers}}, the END Fund, and {{w|Helen Keller International}} on a more integrated neglected tropical diseases (NTD) program.<ref name="Schistosomiasis Control Initiative: Supplementary Information"/> || |
|- | |- | ||
− | | 2014 || || || | + | | 2014 || || Funding || The British {{w|Department for International Development}} awards SCI an additional £16.6 million over four and a half years (June 2014 to December 2018) to extend the program and expand it to an additional two countries.<ref name="Schistosomiasis Control Initiative: Supplementary Information"/> || |
|- | |- | ||
− | | 2014 || || || ACI reaches median coverage for schistosomiasis treatment at 69% in Malawi, 82% in Côte d'Ivoire, and 47% in Uganda.<ref name="SCHISTOSOMIASIS CONTROL INITIATIVEd"/> || | + | | 2014 || || Coverage || ACI reaches median coverage for schistosomiasis treatment at 69% in Malawi, 82% in Côte d'Ivoire, and 47% in Uganda.<ref name="SCHISTOSOMIASIS CONTROL INITIATIVEd"/> || |
|- | |- | ||
− | | 2014 – 2015 || || || SCI reports having delivered 3.1 million treatments in Côte d'Ivoire in the period.<ref name="Schistosomiasis Control Initiative: Supplementary Information"/> || {{w|Côte d'Ivoire}} | + | | 2014 – 2015 || || Coverage || SCI reports having delivered 3.1 million treatments in Côte d'Ivoire in the period.<ref name="Schistosomiasis Control Initiative: Supplementary Information"/> || {{w|Côte d'Ivoire}} |
|- | |- | ||
− | | 2015 || || || ACI reaches median coverage for schistosomiasis treatment at 81% in Mozambique, 93% in Zambia (2015), and 80% in Zanzibar.<ref name="SCHISTOSOMIASIS CONTROL INITIATIVEd"/> || | + | | 2015 || || Coverage || ACI reaches median coverage for schistosomiasis treatment at 81% in Mozambique, 93% in Zambia (2015), and 80% in Zanzibar.<ref name="SCHISTOSOMIASIS CONTROL INITIATIVEd"/> || |
|- | |- | ||
| 2015 – 2016 || || || " During its 2015-16 budget year, SCI planned to deliver around 0.6 million treatments and reported delivering 1.4 million treatments in Côte d'Ivoire"<ref name="Schistosomiasis Control Initiative: Supplementary Information"/> || | | 2015 – 2016 || || || " During its 2015-16 budget year, SCI planned to deliver around 0.6 million treatments and reported delivering 1.4 million treatments in Côte d'Ivoire"<ref name="Schistosomiasis Control Initiative: Supplementary Information"/> || |
Revision as of 17:01, 15 March 2019
This is a timeline of Schistosomiasis Control Initiative.
Contents
Big picture
Time period | Development summary | More details |
---|
Full timeline
Year | Month and date | Event type | Details | Location |
---|---|---|---|---|
2002 | SCI is founded through a US$32 million grant from the Bill and Melinda Gates Foundation[1], to tackle schistosomiasis in sub-Saharan Africa, where infected people are unable to afford the drugs needed for treatment.[2] | |||
2002 | SCI begins program in Uganda, the first operating country.[3] | Uganda | ||
2003 | October | SCI selects six countries for full support: Uganda, Burkina Faso, Niger, Mali, Tanzania, and Zambia. The countries each propose a different implementation approach and management structure for their large-scale schistosomiasis control.[4] | ||
2003 | SCI begins program in Zambia, Zanzibar, and Niger.[3] | Zambia, Zanzibar, Niger | ||
2006 | Funding | SCI receives large grants from the United States Agency for International Development and the Bill & Melinda Gates Foundation to support integrated NTD programs in eight countries for five years to treat lymphatic filariasis, onchocerciasis, and trachoma, in addition to schistosomiasis and soil-transmitted helminths.[1] | ||
2007 | Funding | SCI receives a grant to expand its work to Rwanda and Burundi.[1] | ||
2007 | SCI program starts in Burundi.[3] | Burundi | ||
2010 | SCI begins working in Côte d'Ivoire.[1] | Côte d'Ivoire | ||
2010 | SCI receives £10.5 million (plus separate funding for drugs) from the British Department for International Development for treating schistosomiasis and soil-transmitted helminthiasis in eight countries over five years.[1] | |||
2010 | October | Funding | SCI receives £10.5 million (plus separate funding for drugs) from the British Department for International Development for treating schistosomiasis and soil-transmitted helminthiasis in eight countries over five years.[5][1] | |
2011 | Expansion | SCI begins program in Liberia, Malawi, and Mozambique.[3] | Liberia, Malawi, Mozanbique | |
2012 | Expansion | SCI program starts in Côte d'Ivoire, two years later due to political turmoil.[1][3] | Côte d'Ivoire | |
2012 | Expansion | SCI begins conversations with the Government of Ethiopia about starting a national schistosomiasis treatment program.[1] | Ethiopia | |
2012 | Coverage | SCI reaches median coverage for schistosomiasis treatment at 77% in Malawi.[6] | ||
2013 | Expansion | SCI begins first round of treatment in Ethiopia and Mauritania.[1][3][1][3] | Ethiopia, Mauritania | |
2013 – 2014 | Between November 2013 and April 2014 | SCI funds mapping in Ethiopia.[1] | Ethiopia | |
2014 | Expansion | SCI begins program in the Democratic Republic of the Congo and Madagascar.[3] | Democratic Republic of the Congo, Madagascar | |
2014 | SCI begins working with other partners in Côte d'Ivoire, including Sightsavers, the END Fund, and Helen Keller International on a more integrated neglected tropical diseases (NTD) program.[1] | |||
2014 | Funding | The British Department for International Development awards SCI an additional £16.6 million over four and a half years (June 2014 to December 2018) to extend the program and expand it to an additional two countries.[1] | ||
2014 | Coverage | ACI reaches median coverage for schistosomiasis treatment at 69% in Malawi, 82% in Côte d'Ivoire, and 47% in Uganda.[6] | ||
2014 – 2015 | Coverage | SCI reports having delivered 3.1 million treatments in Côte d'Ivoire in the period.[1] | Côte d'Ivoire | |
2015 | Coverage | ACI reaches median coverage for schistosomiasis treatment at 81% in Mozambique, 93% in Zambia (2015), and 80% in Zanzibar.[6] | ||
2015 – 2016 | " During its 2015-16 budget year, SCI planned to deliver around 0.6 million treatments and reported delivering 1.4 million treatments in Côte d'Ivoire"[1] | |||
2015 – 2016 | Between April 2015 and March 2016 | "SCI spent around $2.1 million in unrestricted funding and $0.8 million in restricted funding in Ethiopia between April 2015 and March 2016."[1] | ||
2015 – 2016 | "Between April 2015 and March 2016, SCI reports that it delivered 890,000 treatments in Uganda; 1.2 million treatments were planned"[1] | |||
2011 | SCI begins program in Nigeria.[3] | Nigeria | ||
2016 | January | "Good Ventures awarded a grant of $1,000,000 to the Schistosomiasis Control Initiative (SCI) for general operating support in January 2016, in recognition of the organization’s earning a “top charity” ranking from GiveWell in 2015. See GiveWell’s review of SCI for more about its activities and to follow its progress."[7] | ||
2016 | August | "GiveWell estimates that programs supported by SCI can deworm a person for approximately $1.26 based (including the estimated cost of SCI’s funding to country programs, SCI’s headquarters costs, cost of donated drugs, and local government involvement)."[6] | ||
2017 | January | "Good Ventures awarded a grant of $13,500,000 to the Schistosomiasis Control Initiative (SCI) for general operating support in January 2017, in recognition of its earning a “top charity” ranking from GiveWell in 2016."[8] | ||
2017 | GiveWell allocates 100% of its discretionary fund to the SCI in the fourth quarter of the year, totalling US$5.6 million.[9] | |||
2018 | "In Q4 2017, GiveWell allocated 100% of its discretionary fund to the SCI, totalling $5.6 million. It allocated a further $0.89 million to the SCI in Q1 2018, which was 30% of its discretionary fund for that period."[9] |
Meta information on the timeline
How the timeline was built
The initial version of the timeline was written by User:Sebastian.
Funding information for this timeline is available.
Feedback and comments
Feedback for the timeline can be provided at the following places:
- FIXME
What the timeline is still missing
Timeline update strategy
See also
External links
References
- ↑ 1.00 1.01 1.02 1.03 1.04 1.05 1.06 1.07 1.08 1.09 1.10 1.11 1.12 1.13 1.14 1.15 1.16 "Schistosomiasis Control Initiative: Supplementary Information". givewell.org. Retrieved 11 March 2019.
- ↑ "Ten million Africans treated by international disease treatment programme". imperial.ac.uk. Retrieved 12 March 2019.
- ↑ 3.0 3.1 3.2 3.3 3.4 3.5 3.6 3.7 3.8 "OUR REACH". schistosomiasiscontrolinitiative.org. Retrieved 12 March 2019.
- ↑ "Schistosomiasis Control Initiative (SCI) — 2015 Review, Updated April 2016". givewell.org. Retrieved 12 March 2019.
- ↑ "Imperial initiative to protect children from tropical disease awarded £25m government backing". imperial.ac.uk. Retrieved 11 March 2019.
- ↑ 6.0 6.1 6.2 6.3 "SCHISTOSOMIASIS CONTROL INITIATIVE". givingwhatwecan.org. Retrieved 12 March 2019.
- ↑ "Schistosomiasis Control Initiative — General Support (2016)". openphilanthropy.org. Retrieved 11 March 2019.
- ↑ "Schistosomiasis Control Initiative — General Support (2017)". openphilanthropy.org. Retrieved 11 March 2019.
- ↑ 9.0 9.1 "HOW YOUR MONEY IS SPENT". schistosomiasiscontrolinitiative.org. Retrieved 15 March 2019.